0001104659-23-062821.txt : 20230519 0001104659-23-062821.hdr.sgml : 20230519 20230519204437 ACCESSION NUMBER: 0001104659-23-062821 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220405 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaturvedi Pravin R CENTRAL INDEX KEY: 0001916935 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 23942180 MAIL ADDRESS: STREET 1: C/O JAGUAR HEALTH INC., 200 PINE STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 4/A 1 tm2316214-9_4aseq1.xml OWNERSHIP DOCUMENT X0407 4/A 2022-04-05 2022-04-06 0 0001585608 Jaguar Health, Inc. JAGX 0001916935 Chaturvedi Pravin R C/O JAGUAR HEALTH, INC. 200 PINE STREET, SUITE 400 SAN FRANCISCO CA 94104 0 1 0 0 Chief Scientific Officer 0 Common Stock 2022-04-05 4 M 0 10000 A 10000 D Restricted stock units 2022-04-05 4 A 0 10000 0 A Common Stock 10000 20000 D Restricted stock units convert into common stock on a one-for-one basis. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock. On April 6, 2022, the reporting person filed a Form 4 that erroneously indicated that 3,333 restricted stock units had vested on April 5, 2022 and that the reporting person beneficially owned 6,666 restricted stock units following such vesting. In fact, 10,000 restricted stock units had vested on such date and the reporting person beneficially owned 20,000 restricted stock units following such vesting. /s/ Pravin R. Chaturvedi 2023-05-19